Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00224003
Status:
COMPLETED
Last Update Posted:
2009-09-28
First Post:
2005-09-13
Brief Title:
Study of the Safety and Efficacy of Ferrlecit Maintenance Dosing in Pediatric Hemodialysis Patients
Sponsor:
Watson Pharmaceuticals
Organization:
Watson Pharmaceuticals
Study Overview
Official Title:
Open-Label Multi-Center Study of the Safety and Efficacy of Ferrlecit in the Maintenance of Iron Stores in Pediatric Hemodialysis Patients Receiving Epoetin
Status:
COMPLETED
Status Verified Date:
2009-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A phase 4 clinical investigation in iron-replete pediatric hemodialysis patients whose legal guardian had provided signed informed consent and who had satisfied the inclusion and exclusion criteria of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| FDA | None | None | None |